Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (211-220 of 467) with videos related to

Pageof 47
Sort By:
The Journal of Biological Chemistry|February 21, 2023
p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsisCarli E Mager, Justin M Mormol, Evan D Shelton, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)Mark Opdam, Nigel Ultee, Jill J J Geenen, et al.
Journal of Clinical Pathology|June 1, 2025
Prognostic value of immunohistochemical markers of intratumoral hypoxia in pregnancy-associated breast cancerCarsten F J Bakhuis, Paul J van Diest, Britt B M Suelmann, et al.
Annals of Hematology|April 3, 2004
Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefitsL P Koh, W Y K Hwang, C H Tan, et al.
Molecular Imaging and Biology|February 18, 2014
Dynamics of IGF-1R expression during endocrine breast cancer treatmentSandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2017
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort StudyAnne Kuijer, Marieke Straver, Bianca den Dekker, et al.
BMC Cancer|December 31, 2013
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolitesNynke G L Jager, Rutger H T Koornstra, Andrew D Vincent, et al.
Breast (Edinburgh, Scotland)|August 8, 2016
Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 studyMette S van Ramshorst, Erik van Werkhoven, Aafke H Honkoop, et al.
Bone Marrow Transplantation|February 16, 2010
Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myelomaD Tan, Z Lao, Y Loh, et al.
Veterinary and Comparative Oncology|June 6, 2022
Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumoursEdward Cheng, Ryan N Jennings, Carolyn L Chen, et al.
Pageof 47

Showing results (211-220 of 467) with videos related to

Sort By:
Pageof 47
The Journal of Biological Chemistry|February 21, 2023
p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsisCarli E Mager, Justin M Mormol, Evan D Shelton, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)Mark Opdam, Nigel Ultee, Jill J J Geenen, et al.
Journal of Clinical Pathology|June 1, 2025
Prognostic value of immunohistochemical markers of intratumoral hypoxia in pregnancy-associated breast cancerCarsten F J Bakhuis, Paul J van Diest, Britt B M Suelmann, et al.
Annals of Hematology|April 3, 2004
Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefitsL P Koh, W Y K Hwang, C H Tan, et al.
Molecular Imaging and Biology|February 18, 2014
Dynamics of IGF-1R expression during endocrine breast cancer treatmentSandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2017
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort StudyAnne Kuijer, Marieke Straver, Bianca den Dekker, et al.
BMC Cancer|December 31, 2013
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolitesNynke G L Jager, Rutger H T Koornstra, Andrew D Vincent, et al.
Breast (Edinburgh, Scotland)|August 8, 2016
Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 studyMette S van Ramshorst, Erik van Werkhoven, Aafke H Honkoop, et al.
Bone Marrow Transplantation|February 16, 2010
Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myelomaD Tan, Z Lao, Y Loh, et al.
Veterinary and Comparative Oncology|June 6, 2022
Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumoursEdward Cheng, Ryan N Jennings, Carolyn L Chen, et al.
Pageof 47